Patents by Inventor Flemming Mark Christensen

Flemming Mark Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6001627
    Abstract: The present invention relates to rhamnogalacturonases derived from a strain of Aspergillus japonicus which (a) has a pH-optimum between 6.5 and 7.0; (b) retains at least 80% of the maximal activity throughout the pH range of 5.5-12; (c) has a temperature optimum of about 40.degree. C.; and (d) retains at least 80% of the maximal activity throughout the temperature range of 20-60.degree. C. The present invention relates to rhamnogalacturonases derived from a strain of Aspergillus aculeatus which (a) has a pH-optimum of about 5.0; (b) retains at least 80% of the maximal activity throughout the pH range of 3-6.5; (c) has a temperature optimum of about 40.degree. C.; and (d) retains at least 80% of the maximal activity throughout the temperature range of 5-50.degree. C.
    Type: Grant
    Filed: September 11, 1995
    Date of Patent: December 14, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Kurt Dorreich, Henrik Dalb.o slashed.ge, Jan M.o slashed.ller Mikkelsen, Flemming Mark Christensen, Torben Halkier
  • Patent number: 5919698
    Abstract: The present invention relates to a one-step method for disinfection and cleaning of contact lenses of the type using hydrogen peroxide as the disinfecting agent and a protease as the cleaning agent, comprising the following steps: a) disinfection of the contact lenses in an aqueous disinfecting solution comprising from 1 wt. % to 5 wt. % hydrogen peroxide at a pH not acceptable to the eyes, b) cleaning the contact lenses by subjecting the contact lenses to a protease being inactivated within a period of time at a pH level not acceptable to the eyes, c) neutralization of the hydrogen peroxide in the aqueous disinfecting solution with a microbial catalase being substantially active at pH 3.0 to 7.0, d) adjusting the pH in the aqueous disinfecting solution to a pH level acceptable to the eyes.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: July 6, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Lykke Sorensen, Flemming Mark Christensen